Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             57 results found
no title author magazine year volume issue page(s) type
1 Acute liver injury and survival in patients with SARS-Cov-2 from the Hospital Central Militar Figueroa-Peña, A.

19 S1 p. 26-27
article
2 Analysis of the molecular interaction of pirfenidone with PPAR-gamma and effects on the beta-catenine pathway in HEPG2 line Monroy-Ramírez, H.C.

19 S1 p. 9
article
3 Aspartate aminotransferase as predictor of severity in SARSCoV-2 infection: linear regression model Servín-Caamaño, A.

19 S1 p. 22
article
4 Cell death in patients with different alcohol consumption and alcoholic liver disease Martínez-Castillo, M.

19 S1 p. 23
article
5 Cellular and molecular characterization of the pirfenidone effects on an hepatocarcinogésis experimental model Silva-Gómez, J.A.

19 S1 p. 8-9
article
6 Characteristics of ascitic fluid and flow of the portal system in cirrotic patients with diagnosis of portal vein thrombosis Campoverde-Espinoza, C.A.

19 S1 p. 15
article
7 Characteristics of the overlap syndrome (HAI / CBP, HAI / CEP): a cohort type study in a reference center in Mexico during the period 2008–2018 Vélez Carrión, A.

19 S1 p. 17
article
8 Characterization of patients with primary sclerosing cholangitis in a third level hospital López Ladrón de Guevara, V.

19 S1 p. 16
article
9 Classification of alcohol consumption pattern in the Mexican population Martínez-Castillo, M.

19 S1 p. 22-23
article
10 “CLIF-C ACLF mortality predictive utility in patients with acute liver failure in chronic “ACLF” in the hospital Juarez de Mexico population Moreira-Alcívar, J.

19 S1 p. 12-13
article
11 Clinical and epidemiological characteristics of patients with autoimmune hepatitis in a center of Northeast Mexico Kuljacha-Gastélum, A.L.

19 S1 p. 6
article
12 Clinical, demographic, radiological and histological features of a series of liver adenomas in a reference hospital Thomas Lora, F.C.

19 S1 p. 16-17
article
13 Comparison of two ROC curve-based methods for determining the cross-point critting frequency in the diagnosis of EHM Villaseñor-Todd, A.

19 S1 p. 19-20
article
14 Correlation between the index platelet/ spleen diameter with the presence of esophageal varices by endoscopy in cirrhotic patients from the State of Mexico Ganado-Escobar, A.M.

19 S1 p. 17
article
15 Correlation of serum ferritin concentrations with laboratory and demographic paramters and its alteraration by different clinical conditions in patients with liver disease Tijerina-Márquez, R.

19 S1 p. 4-5
article
16 Development of a defatting strategy to reduce lipid accumulation and improve the viability of steatotic grafts in liver transplantation Casillas-Ramírez, A.

19 S1 p. 7-8
article
17 Development of the analytical method for the quantification of 3-nitrotirosin and 3-chlorothyrosin in human plasma as potential biomarkers to evaluate minimal liver encephalopathy (MHE) Villaseñor Todd, A.

19 S1 p. 21
article
18 Effect of chronic alcohol intake in a pre-clinical model with cholesterol overload Alonso-Mora, J.M.

19 S1 p. 26
article
19 Effect of pangenotype treatment on chronic hepatitis C. Real life studio Santana Salgado, I.

19 S1 p. 25
article
20 Evaluación de marcadores fibroticos en células estelares expuestas al extracto metanolico de Turnera diffusa Rodriguez-Rodriguez, D.R.

19 S1 p. 18-19
article
21 Evaluation of atherosclerotic risk in patients with chronic hepatitis C infection Solís, J.G.

19 S1 p. 27-28
article
22 Evaluation of cyclooxigenase inhibitors in hepatic isquemia-reperfusion injury in Wistar rats Garza, A.G.

19 S1 p. 27
article
23 Evaluation of IL-1RA, IL-1β IFN-γ and CXCL-10 as mediators of damage and hepatic repair in chronic hepatitis and fibrosis progresion Hernández-Barragán, A.

19 S1 p. 24
article
24 Evaluation of TLR-4 in peripheral M1 monocytes and IL-6 and CXCL-8 in alcoholic liver disease Martínez-Castillo, M.

19 S1 p. 24
article
25 Experience in treatment with direct action antivirals in patients with HCV-HIV coinfection Martínez Gómez, N.

19 S1 p. 25
article
26 Experience of Yttrium-90 radioembolization in patients with hepatocellular carcinoma Zapote Hernández, B.

19 S1 p. 21-22
article
27 Frequency and characteristics of alterations in liver function tests (LFT) in adult patients with COVID-19 (preliminary report) Menéndez-Morales, D.

19 S1 p. 18
article
28 Gallbladder adenomyomatosis Aquino-Matus, J.

19 S1 p. 3
article
29 Hepatic and gastrointestinal manifestations of SARS-COV-2 infection (COVID-19) Aquino-Matus, J.

19 S1 p. 25-26
article
30 Hepatocelullar carcinoma is a major risk factor for the development of portal ven thrombosis in cirrhotic patients Espinoza, C.A.

19 S1 p. 13-14
article
31 Hepatoprotective effect of nifedipine against ischemia-reperfusion injury in rats Villarreal-Benítez, A.

19 S1 p. 10
article
32 Hepatoprotective effect of sodium (S)-2-hydroxyglutarate against ischemia-reperfusion injury in Wistar rats Cienfuegos-Pecina, E.

19 S1 p. 8
article
33 HGF induces a protective response in a preclinical model of nephropathy induced by acute cholestasis Lopez-Ramirez, J.

19 S1 p. 3-4
article
34 Impact of liver enzymes on SARSCoV-2 infection and on the severity of clinical disease Servín-Caamaño, A.

19 S1 p. 20
article
35 Incidence and impact of bacterial infection on the forecast of patients with acute liver failure on chronic “ACLF”, hospital juárez de México Moreira-Alcívar, J.

19 S1 p. 12
article
36 Incidental finding of fatty liver in necropsies Bravo-Espinoza, I.E.

19 S1 p. 1
article
37 Main clinical characteristics of hospitalized cirrhotic patients with acute on chronic liver failure Díaz-Valencia, C.I.

19 S1 p. 2
article
38 Mexican experience with direct-acting antivirals in the treatment of hepatitis C Pérez Hernández, J.L.

19 S1 p. 16
article
39 Molecular, histological and biochemical changes in a NASH murine model whit a diet high in fats and sugars Rodríguez Sanabria, J.S.

19 S1 p. 7
article
40 Moringa oleífera decreases insulin resistance, novo lipogenesis and modifies the expression of mirnas in a non-alcoholic esteatohepatitis model Monraz-Méndez, A.

19 S1 p. 5
article
41 Most commonly liver function test alterations on adult patients with septic shock Belmonte-Garcia, F.

19 S1 p. 15
article
42 Normal values and diagnostic errors of psychometric tests and critical flicker frequency in vulnerable Mexican population Quiroz Compeán, F.

19 S1 p. 2
article
43 Obesity and diabetes as a risk factor of chronic disease of the liver in the regional hospital Rodríguez-Villa, P.

19 S1 p. 1-2
article
44 Pirfenidone induces epigenetic changes modulating the activity of the ppargamma-SIRT1-DNMT1 axis in hepatic stellate cells Monroy-Ramírez, H.C.

19 S1 p. 6-7
article
45 Precipitating factors and epidemiological characteristics in acute on chronic liver failure of a unity medical of high speciality Wade Isidro, M.E.

19 S1 p. 13
article
46 Prevalence and characteristics of cirrhotic patients with portal vein thrombosis admited in the Gastroenterology Department of the Hospital General de Mexico Campoverde-Espinoza, C.A.

19 S1 p. 14
article
47 Prevalence and characteristics of non-cirrhotic patients with thrombosis of the portal system Campoverde-Espinoza, C.A.

19 S1 p. 14-15
article
48 Prevalence of acute kidney injury in hospitalized patients with cirrhosis and their transition to chronic kidney disease Rodríguez-Granados, V.

19 S1 p. 4
article
49 Prevalence of spontaneous bacterial peritonitis in patients with hepatic cirrhosis in the military central hospital Perez-Méndez, E.

19 S1 p. 19
article
50 Prolonged-release pirfenidone decreases hepatic miRNAs expression in a NAFLD/NASH experimental model Escutia-Gutiérrez, R.

19 S1 p. 5-6
article
51 Prolonged-release pirfenidone prevents myocardial fibrosis in a mouse nonalcoholic steatohepatitis model Gutiérrez-Cuevas, J.

19 S1 p. 9
article
52 Reported resistance to different antibiotics in cirrhotic patients with spontaneous bacterial peritonitis Meléndez Alvarado, T.F.

19 S1 p. 10-11
article
53 Spontaneous bacterial peritonitis and bacterioascitis. Microbiological and resistance profile in a third level hospital Ganado-Escobar, A.M.

19 S1 p. 18
article
54 Sustained viral response in patients with hepatitis C and chronic kidney disease in hemodialysis and treatment with direct acting antivirals in the UMAE 71 Jasso-Baltazar, E.A.

19 S1 p. 11
article
55 The clinical expression of lysosomal acid lipase severity in patients with cryptogenic cirrhosis Solano-Urrusquieta, A.

19 S1 p. 13
article
56 The fructose enhances the HCC progression in mice under a high intake of fructose in dieT Chávez-Rodríguez, L.

19 S1 p. 3
article
57 Total cholesterol/high-density lipoprotein cholesterol ratio, high-density lipoprotein triglycerides/colesterol with hepatic fat infiltration grade in non-alcoholic fat liver Asencio-Barrientos, C.N.

19 S1 p. 11-12
article
                             57 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands